Clincosm LogoSign in Get a demo

capecitabine

Showing 1 - 13 of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tislelizumab, Bevacizumab, Oxaliplatin Trial in Beijing (Tislelizumab+Bevacizumab+Oxaliplatin+Capecitabine)

Recruiting
  • Tislelizumab
  • +7 more
  • Beijing, China
    Lin Yang
Jul 21, 2023

MSI-H Colorectal Cancer, Tislelizumab, Oxaliplatin Trial (Tislelizumab)

Not yet recruiting
  • MSI-H Colorectal Cancer
  • +3 more
  • (no location specified)
Apr 23, 2023

Metastatic HER2 Negative Breast Carcinoma, Brain Metastases, Capecitabine Trial in Changsha (UTD1 combined with capecitabine)

Recruiting
  • Metastatic HER2 Negative Breast Carcinoma
  • +3 more
  • UTD1 combined with capecitabine
  • Changsha, China
    Quchang Ouyang
Sep 9, 2022

Radiotherapy, PD-1 Inhibitor, Capecitabine Trial in Zhuhai (SBRT radiotherapy + Conventionally fractionated radiotherapy, PD-1

Recruiting
  • Radiotherapy
  • +3 more
  • SBRT radiotherapy + Conventionally fractionated radiotherapy
  • +2 more
  • Zhuhai, Guangdong, China
    Fifth Affilliated Hospital of Sun Yat-sen University
Apr 13, 2022

Breast Tumors, Breast Diseases, Capecitabine Trial in China (RC48-ADC, Lapatinib, Capecitabine)

Recruiting
  • Breast Neoplasms
  • +5 more
  • Beijing, Beijing, China
  • +66 more
Feb 18, 2022

Colo-rectal Cancer, Capecitabine, Cetuximab Trial in Chengdu (mCapOX plus cetuximab, mFOLFOX6 plus cetuximab)

Recruiting
  • Colo-rectal Cancer
  • +2 more
  • mCapOX plus cetuximab
  • mFOLFOX6 plus cetuximab
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Sep 1, 2021

Biliary Tract Cancer, Programmed Cell Death 1 Ligand 1 Gene Mutation, Targeted Molecular Therapy Trial in Beijing (Camrelizumab,

Not yet recruiting
  • Biliary Tract Cancer
  • +3 more
  • Beijing, Beijing, China
    Beijing Friendship Hospital
Jan 20, 2021

Neuroendocrine Tumors, Neuroendocrine Carcinoma, Temozolomide Trial in Seoul (TEMCAP)

Active, not recruiting
  • Neuroendocrine Tumors
  • +3 more
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Dec 13, 2020

Cholangiocarcinoma, Biliary Tract Cancer, Adjuvant Chemo Trial in Seoul (Gemcitabine plus cisplatin, Capecitabine)

Recruiting
  • Cholangiocarcinoma
  • +5 more
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Jun 13, 2020

Capecitabine-based Chemotherapy Toxicities in Chinese Solid

Unknown status
  • Solid Tumor
  • +4 more
  • detection of genotype
  • Beijing, Beijing, China
  • +6 more
Aug 27, 2019

Stomach Tumors, Gastrointestinal Tumors, Stomach Diseases Trial (Apatinib, Capecitabine)

Not yet recruiting
  • Stomach Neoplasms
  • +7 more
  • (no location specified)
Mar 23, 2019

Discovery and Validate of Multi-genetic Biomarkers for

Unknown status
  • Colorectal Cancer
  • Capecitabine
  • No intervention
  • Shanghai, Shanghai, China
    Department of medicine of Shanghai Changzheng Hospital
Jan 22, 2017

Metronomic Chemotherapy of Capecitabine After Standard Adjuvant

Unknown status
  • Breast Cancer
  • +2 more
    • Xi'an, Shaanxi, China
      Xijing Hospital ，Fourth Military Medical University
    Nov 11, 2014